Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 59 Pancreatic Neoplasms 33 Colonic Neoplasms 31 Rectal Neoplasms 30 Stomach Neoplasms 22 Neoplasm Metastasis 19 Carcinoma, Non-Small-Cell Lung 19 Neoplasms 16 Unspecified Adult Solid Tumor, Protocol Specific 15 Esophageal Neoplasms 12 Ovarian Neoplasms 8 Gallbladder Neoplasms 7 Appendiceal Neoplasms 7 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Lung Neoplasms 6 Carcinoma, Renal Cell 6 Breast Neoplasms 6 Bile Duct Neoplasms 6 Peritoneal Neoplasms 5 Liver Neoplasms 5 Gastrointestinal Neoplasms 5 Carcinoma, Hepatocellular 5 Adenocarcinoma 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Fallopian Tube Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Pancreatic Ductal 4 Squamous Cell Carcinoma of Head and Neck 3

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Locally-advanced Rectal Cancer × Oxaliplatin × Clear all

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡